News Focus
News Focus
Followers 57
Posts 10479
Boards Moderated 0
Alias Born 09/21/2016

Re: Jonjones325 post# 188956

Tuesday, 04/09/2019 8:27:29 AM

Tuesday, April 09, 2019 8:27:29 AM

Post# of 519072
jonjones325

Merck - Okay guys. We want to partner with you on a few new indications but we can't have another BP walk in and take you over. That's a potential liability for us.

Listen. Get some protection and let's talk.

Missling - No prob. Blank check preferreds on the way.



No Better Friend. No Worse Enemy.

IMO, it is also notable that Dr.M. and staff have done this w/very little systemic guidance(as far as we know). There is no model or example we can identify showing how to get this done.
We have two synchronous elements, one is the science and the other is the management strategy. The odds against getting this done and staying in one piece are massive. And, when they are done a lot of CNS patients who had no chance for a life will then have hope. priceless.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News